Ragner Liedman

Learn More
OBJECTIVE To estimate endometrial thickness by transvaginal ultrasound technique (TVU) in patients treated with tamoxifen; and to compare the results with hysteroscopy and directed biopsy, and to(More)
Endometrial thickness as measured by ultrasound during tamoxifen treatment has previously been reported. However, there has not been any study investigating endometrial thickness before treatment and(More)
Pallents with breast cancer exhibit an increased risk of developing cancer from other organs, a risk that might increase due to tamoxifen treatment. This drug has been found to cause activation of(More)
OBJECTIVE To investigate gene expressions for neurohypophyseal and ovarian hormones as well as their receptors in the endometrium of women with primary dysmenorrhoea and healthy subjects at(More)
BACKGROUND A model to study the effect of vasopressin V1a antagonist in dysmenorrhea. METHODS A double-blind, randomized, placebo-controlled, cross-over trial was performed. Eight patients with(More)
  • 1